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Abstract—The reaction of isoxazolo[3,4-d ]pyrimidine 1 and cyanoolefins 2 in the presence of triethylamine (Et3N) as a catalyst
afforded an unprecedented one-pot synthesis of biologically important pyrido[2,3-d ]pyrimidine oxides 3 in excellent yields. © 2003
Elsevier Science Ltd. All rights reserved.
The importance of uracil and its annelated derivatives
is well recognised by synthetic1 as well as biological2
chemists. Organic N-oxides are an important class of
compounds that possess a wide range of biological
activities.3 Readily available cyanoolefins are versatile
reagents having diverse uses in organic synthesis.4 Uti-
lizing these organic synthons, we studied their reactivity
with 6-amino and 6-hydrazino uracils5 which involved
electrophilic attack of the cyanoolefins on the amino
and hydrazino uracils leading to the formation of
pyrido[3,4-d ]pyrimidines and pyrazolo[2,3-d ]pyri-
midines, respectively. In continuation of our studies on
uracils6 we describe in this communication the results of
reactions between isoxazolo[3,4-d ]pyrimidine and
cyanoolefins in the presence of triethylamine as a cata-
lyst which affords an unprecedented one-pot synthesis
of pyrido[2,3-d ]pyrimidine oxides of biological impor-
tance in excellent yields (Scheme 1).
In our reaction, equimolar amounts of isoxazolo[3,4-d ]-
pyrimidine 1 (0.175 g, 1 mmol) and cyanoolefin 2a
(0.154 g, 1 mmol) in the presence of a catalytic amount
of Et3N (0.01 g) were refluxed in ethanol for 1 h. The
solvent was removed under reduced pressure. The
residue was chromatographed over silica gel using chlo-
roform–ethyl acetate (50:50) as eluent. An 80% yield of
the product (0.197 g) was obtained and identified as
6-cyano-7-aminopyrido[2,3-d ]pyrimidine-2,4(1H,3H)-
dione-8-oxide 3a7a from spectroscopic data and elemen-
tal analysis. Its IR spectrum exhibited sharp bands
Scheme 1.
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Scheme 2.
at 3250 cm−1 (NH2), 2220 (CN) and at 1625 (N+O−).
The 1H NMR spectrum showed singlets at  8.20 for
the aromatic protons. Similarly compound 1 was
reacted with 2b–c. When substituted cyanoolefins 2b–c
(R1=p-CH3OC6H4, p-ClC6H4) were employed, the
same product 3a was obtained. The corresponding alde-
hydes 4 were detected (by TLC) as byproducts in the
reaction mixtures. The reaction was generalised by
reacting the isoxazolo[3,4-d ]pyrimidine 1 with a number
of -cyanocinamates 2d–f and -cyanocinamides 2g–h
under identical conditions. As expected the same
product 3b7b was obtained from the reaction of the
substituted cinamates 2d–f with 1. The aldehydes 4
eliminated were detected in each case. Similarly the
-cyanocinamides 2g–h gave the same product 3c7c
when reacted with 1.
A possible mechanism of the reaction is outlined in
Scheme 2. The reaction occurs via initial keteneimine
formation from the cyanoolefin in the presence of tri-
ethylamine. The keteneimine undergoes [4+2] cycload-
dition with the isoxazolo[3,4-d ]pyrimidine to give the
adduct [A]. This is then attacked by ethanol and water
molecules resulting in the rupture of the CO bond to
give the hydroxy intermediate [B], which eliminates an
arylaldehyde and rearranges to afford the product 3.
Further study of this effective reaction is in progress. In
conclusion, our results have demonstrated a very simple
and effective ring transformation process leading to an
important class of annulated uracils of biological
significance.
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